rM2e-ΔPly protein immunization induces protection against influenza viruses and its co-infection with Streptococcus pneumoniae in mice

Antigen-Presenting, Self-Assembled Protein Nanobarrels as an Adjuvant-Free Vaccine Platform against Influenza Virus

(2021) Sukmo Kang et al.   ACS Nano

Biomineralization improves the stability of a Streptococcus pneumoniae protein vaccine at high temperatures

(2021) Yajun Min et al.   Nanomedicine

Comprehensive mutagenesis to identify amino acid residues contributing to the difference in thermostability between two originally thermostable ancestral proteins

(2021) Satoshi Akanuma et al.   PLoS One

Next-generation influenza vaccines: opportunities and challenges

(2020) Chih-Jen Wei et al.   NATURE REVIEWS DRUG DISCOVERY

IL-6 During Influenza-Streptococcus pneumoniae Co-Infected Pneumonia—A Protector

(2020) Xuemei Gou et al.   Frontiers in Immunology

A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection

(2020) Valentina Bernasconi et al.   Mucosal Immunology

Residues 315 and 369 in HN Protein Contribute to the Thermostability of Newcastle Disease Virus

(2020) Baoyang Ruan et al.   Frontiers in Microbiology

Development of a Universal Influenza Vaccine

(2019) Leonardo D. Estrada et al.   JOURNAL OF IMMUNOLOGY

Current and future influenza vaccines

(2019) Seiya Yamayoshi et al.   NATURE MEDICINE

Recent advances in the improvement of enzyme thermostability by structure modification

(2019) Zhe Xu et al.   CRITICAL REVIEWS IN BIOTECHNOLOGY

Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus

(2018) Andrea J Sant et al.   CURRENT OPINION IN IMMUNOLOGY

Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture

(2018) Daniela S. Rajão et al.   Frontiers in Microbiology

The Pathway to a Universal Influenza Vaccine

(2017) Catharine I. Paules et al.   IMMUNITY

M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection

(2017) D G Eliasson et al.   Mucosal Immunology

Subcutaneous Immunization with Fusion Protein DnaJ-ΔA146Ply without Additional Adjuvants Induces both Humoral and Cellular Immunity against Pneumococcal Infection Partially Depending on TLR4

(2017) Yufeng Su et al.   Frontiers in Immunology

Human Influenza Virus Infections

(2016) Christin Peteranderl et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease

(2015) Agnieszka Rynda-Apple et al.   INFECTION AND IMMUNITY

1918 pandemic influenza virus andStreptococcus pneumoniaeco-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans

(2015) Kathie-Anne Walters et al.   JOURNAL OF PATHOLOGY

Reducing the loss of vaccines from accidental freezing in the cold chain: The experience of continuous temperature monitoring in Tunisia

(2015) John Lloyd et al.   VACCINE

Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines

(2015) Yu-Na Lee et al.   Immune Network

Mucosal Immunization with Recombinant Fusion Protein DnaJ-ΔA146Ply Enhances Cross-Protective Immunity against Streptococcus pneumoniae Infection in Mice via Interleukin 17A

(2014) Yusi Liu et al.   INFECTION AND IMMUNITY

Serum Antibody Response to Matrix Protein 2 Following Natural Infection With 2009 Pandemic Influenza A(H1N1) Virus in Humans

(2013) Weimin Zhong et al.   JOURNAL OF INFECTIOUS DISEASES

Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults

(2012) Maria Ines Barría et al.   JOURNAL OF INFECTIOUS DISEASES

Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus

(2012) Min-Chul Kim et al.   MOLECULAR THERAPY

Stabilization of vaccines and antibiotics in silk and eliminating the cold chain

(2012) Jeney Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus

(2011) Dubravka Grdic Eliasson et al.   VACCINE

Evolutionary genomics of the pandemic 2009 H1N1 influenza viruses (pH1N 1v)

(2011) Yanhua Qu et al.   Virology Journal

Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection

(2010) K. El Bakkouri et al.   JOURNAL OF IMMUNOLOGY

Immunization with a Combination of Three Pneumococcal Proteins Confers Additive and Broad Protection against Streptococcus pneumoniae Infections in Mice

(2009) K. Wu et al.   INFECTION AND IMMUNITY

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys

(2009) Tong-Ming Fu et al.   VACCINE

CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine

(2008) Dubravka Grdic Eliasson et al.   VACCINE